Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia.
Human psychopharmacology 2011 Jan 26 (1): 28-34.
Bishop Jeffrey R, Miller Del D, Ellingrod Vicki L, Holman Timot
Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment.
Schizophrenia research 2005 Sep 77 (2-3): 253-60.
Bishop Jeffrey R, Ellingrod Vicki L, Moline Jessica, Miller D